Papers
1
Total Citations
4
H-Index
1
About
Jialin Wu is a surgical oncologist whose research focuses on optimizing treatment strategies for gynecologic cancers, with a particular emphasis on cervical cancer in overweight and obese patients. Her most-cited work, a 2024 retrospective cohort study comparing surgical and oncological outcomes across different surgical approaches, directly addresses a critical gap in clinical practice: how to safely and effectively operate on patients with a body mass index of 24.0 or higher. By analyzing data from 382 patients, Wu’s study provides evidence-based guidance on which surgical techniques—such as minimally invasive versus open approaches—offer the best balance of safety, recovery, and long-term cancer control for this growing patient population. This contribution is especially significant given the rising global rates of obesity and its impact on surgical complexity. While her work is early in its citation trajectory, the study’s practical relevance has already garnered attention from clinicians seeking to improve outcomes for higher-risk patients. Wu’s research exemplifies how tailored surgical decision-making can reduce complications and enhance oncologic results, marking her as a rising voice in the field of gynecologic oncology.
Research Focus
Key Achievements
Top Papers
- 1